Results 81 to 90 of about 10,083 (200)

Ecstasy-Induced Caspase Expression Alters Following Ginger Treatment

Basic and Clinical Neuroscience, 2013
Introduction: Exposure to 3-4, methylenedioxymethamphetamine (MDMA) leads to cell death. Herein, we studied the protective effects of ginger on MDMA- induced apoptosis.
Sara Soleimani Asl, Bagher Pourheydar, Fataneh Dabaghian, Akram Nezhadi, Amir Roointan, Mehdi Mehdizadeh   +5 more
doaj  

Peculiar Botryoid Lymphocytosis After Heat Stroke

eJHaem, Volume 7, Issue 4, August 2026.
Sacha Mandel, Jean‐François Lesesve
wiley   +1 more source

MDMA and mouth ulcers [PDF]

British Dental Journal, 2021
openaire   +2 more sources

Special Issue on the Promise of Psychedelic Pharmacology in Neuropsychiatric Drug Development

Pharmacology Research &Perspectives, Volume 14, Issue 4, August 2026.
Andreas Halman, Ross Corriden
wiley   +1 more source

The effect of curcumin on biochemical and hematological indices of red blood cells during and after taking ecstasy in male Wistar rats

Fiyz̤, 2018
Background: The using of ecstasy pills or 3, 4-methylenedioxymethamphetamine (MDMA) has severe damage to various systems of the body, including blood cells.
Naser Khalaji , Yousef Rasmi , Fahimeh Sadeghi   +2 more
doaj  

Acute Effects of Ecstasy on Memory Are more Extensive than Chronic Effects

Basic and Clinical Neuroscience, 2014
Introduction: Exposure to 3, 4- methylenedioxymethamphetamine (MDMA) could lead to serotonergic system toxicity in the brain. This system is responsible for learning and memory functions.
Mohamad Bakhtiar Hesam Shariati, Maryam Sohrabi, Siamak Shahidi, Ali Nikkhah, Fatemeh Mirzaei, Mehdi Medizadeh, Sara Soleimani Asl   +6 more
doaj  

Harm reduction behaviours and harm experiences of people who use 3,4-methylenedioxymethamphetamine (MDMA) in Aotearoa New Zealand

Harm Reduction Journal
Background 3,4-Methylenedioxymethamphetamine (MDMA) is drug of high prevalence in Aotearoa New Zealand and is the primary drug analysed by legal drug checking services.
Jai Whelan, Geoff Noller, Ryan D. Ward
doaj   +1 more source

Cost-effectiveness of midomafetamine-assisted therapy (MDMA-AT) in chronic and treatment-resistant post-traumatic stress disorder of moderate or higher severity: A health-economic model.

PLoS ONE
ObjectiveTo explore the cost-effectiveness of midomafetamine-assisted therapy (MDMA-AT) compared to placebo with therapy (PT) in US healthcare settings.MethodsA health state-transition model was used to analyze the cost-effectiveness of MDMA-AT for ...
Filip Stanicic, Vladimir Zah, Dimitrije Grbic, Debra De Angelo   +3 more
doaj   +1 more source

Psychedelic-assisted therapy - supposedly paradigm-shifting research with poor attempts at hypotheses falsifying and questionable ethics

EXCLI Journal : Experimental and Clinical Sciences
Bor Luen Tang
doaj   +1 more source

Semantic confusion between "MD" and MDMA in Indian Addiction Psychiatry Practice. [PDF]

Indian J Psychiatry
Seervi A, Sharma I.
europepmc   +1 more source